Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.
On 31 March 2009, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary shares at a price of £10.55 per Ordinary share and $30.21 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 January 2009 to 31 March 2009:
Non Executive Director |
Ordinary Shares |
American Depository |
Sir Christopher Gent |
3,199.05 |
|
Prof. Sir Roy Anderson |
799.76 |
|
Dr Stephanie Burns |
|
618.11 |
Mr Lawrence Culp |
|
1,236.22 |
Sir Crispin Davis |
2,488.150 |
|
Sir Deryck Maughan |
|
1,236.22 |
Dr Daniel Podolsky |
|
865.36 |
Sir Ian Prosser |
1,599.53 |
|
Dr Ronaldo Schmitz |
995.26 |
|
Mr Tom de Swaan |
799.76 |
|
Sir Robert Wilson |
740.52 |
|
The Company and the Non-Executive Directors were informed of these allocations on 1 April 2009.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
S M Bicknell
Company Secretary
1 April 2009